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Hypoxia is a common characteristic of many solid tumors that has been associated
with tumor aggressiveness. Limited diffusion of oxygen generates a gradient of oxygen
availability from the blood vessel to the interstitial space and may underlie the recruitment
of macrophages fostering cancer progression. However, the available data based on the
recruitment of circulating cells to the tumor microenvironment has been so far carried
out by conventional co-culture systems which ignore the hypoxic gradient between
the vessel to the tumor interstitium. Here, we have designed a novel easy-to-build cell
culture device that enables evaluation of cellular cross-talk and cell migration while
they are being simultaneously exposed to different oxygenation environments. As a
proof-of-concept of the potential role of differential oxygenation among interacting cells
we have evaluated the activation and recruitment of macrophages in response to hypoxic
melanoma, breast, and kidney cancer cells. We found that hypoxic melanoma and
breast cancer cells co-cultured with normoxic macrophages enhanced their directional
migration. By contrast, hypoxic kidney cells were not able to increase their recruitment.
We also identified well-described hypoxia-induced pathways which could contribute in
the immune cell recruitment (VEGFA and PTGS2 genes). Moreover, melanoma and breast
cancer increased their proliferation. However, oxygenation levels affected neither kidney
cancer cell proliferation nor gene expression, which in turn resulted in no significant
changes in macrophage migration and polarization. Therefore, the cell culture device
presented here provides an excellent opportunity for researchers to reproduce the in vivo
hypoxic gradients in solid tumors and to study their role in recruiting circulating cells to
the tumor in specific types of cancer.
Keywords: hypoxia gradient, macrophage motility, models of host-tumor interactions, novel assay technology,
tumor progression
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INTRODUCTION
Cancer progression in solid tumors is characterized by
rapid cellular growth along with alterations in the stromal
microenvironment all of which foster invasion and spreading
to distant organs. Hypoxia is now recognized as a frequent
and important feature of rapidly growing and aggressive solid
tumors and is the result of the imbalance between the supply and
consumption of oxygen in the tumor. This imbalance is primarily
caused by the high metabolic rate of tumor cells in conjunction
with the presence of aberrant angiogenesis and disorganized
and leaky vascularization (1, 2). In these settings, primary solid
tumors usually present with maladaptive blood flow supply, such
that greater distances between tumor cells and vessels become
apparent (1, 3), with the resultant low values of oxygen partial
pressure (<0.1–5%) in those regions leading to regional tumor
necrosis (3, 4). In contrast, the tumor periphery where the tumor
is advancing and invading is better irrigated by newly developed
vessels (1, 5). In the context of the high metabolic rate of tumor
cells and the limited diffusion of oxygen in the interstitial space,
a distance gradient of oxygen availability emerges between the
blood vessel and adjoining tumor cells. For instance, it has been
reported that at a distance of 200µm from the vessel the oxygen
supply is drastically reduced (6).
There is increasing evidence linking tumor hypoxia with poor
cancer prognosis (2, 6–8). One of the mechanisms through
which hypoxia could enhance the tumor malignant properties
is by inducing changes in the immune system that facilitate
tumor escape from immunosurveillance (2). As part of the
orchestrated response of the tumor, it has become apparent that
macrophages, the most abundant immune cell population in the
majority of solid tumors, play a critical role at each stage of
cancer progression (7). Human and experimental studies have
consistently demonstrated that macrophages are preferentially
recruited to tumors with greater and more extensive hypoxic
regions, and that hypoxia-induced changes in macrophages can
also enhance cancer malignancy (9) (Figure 1). Furthermore, a
recent in vitro study has shown that tumor cells pre-exposed
to hypoxia enhanced the attraction of macrophages toward
the tumor (10). However, notwithstanding the aforementioned
evidence, the available in vitro models that are used to
characterize and reproduce the crosstalk between cancer cells and
host immune cells do not incorporate in their characteristics the
ability to recapitulate the oxygen gradient that exists from the
vessel to the tumor interstitium. In fact, most studies are usually
carried out using conventional migration and invasion assays
in the presence of a homogeneously oxygenated environment
(usually at room air oxygenation). Therefore, the potential
role of the O2 gradient on macrophage recruitment, as well
as other circulating cells, is poorly explored and understood
(11). To address this issue and to further our insights on
the role of oxygen gradients in solid tumor progression,
we developed a novel experimental setting that is capable
of studying the crosstalk between two cell types, with each
of these cells being concurrently subjected to different and
well-controlled oxygen partial pressures. This system further
enabled the creation of differential oxygen environments between
the bottom (hypoxia) and upper (normoxia) compartments
of a conventional transwell porous membrane mimicking
the higher oxygen environments that are present in close
proximity to the vascular network and the hypoxic levels in
other more distant regions where tumor cells are continuously
exposed to poor oxygenation (Figure 1). As proof-of-concept
of this model we also investigated whether differential oxygen
levels mimicking those in the pathophysiologic conditions
that characterize solid tumors could facilitate macrophage
recruitment to the tumor and further promote increased tumor
cell proliferation.
MATERIALS AND METHODS
Cell Culture and Reagents
Mouse macrophages (RAW264.7), mouse melanoma (B16F10),
and mouse renal adenocarcinoma (RENCA) cell lines were
purchased from the American Type Culture Collection (ATCC,
Manassas, VA). Murine breast cancer cells (E0771) were
obtained from CH3 BioSystems (Buffalo, NY). All cell lines
were routinely grown in high glucose Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (Gibco, Gaithersburg, MD), and an antibiotic/antimycotic
solution at final concentrations of 100 U/ml penicillin, 100µg/ml
streptomycin and 0.250µg/ml amphotericin B (Sigma-Aldrich,
St. Louis, MO). Cells were maintained in T-25 tissue culture
flasks (Techno Plastic Products AG, Trasadingen, Switzerland)
in a standard humidified incubator with 5% CO2 balanced-
air at 37◦C. Prior to experimentation, RAW264.7 cells were
serum deprived. Fluorescence-conjugated antibodies purchased
from BioLegend (San Diego, CA) were employed to identify
macrophages (CD45-FITC, clone30-F11) and to determine their
phenotype (CD86-PerCP/Cy5.5 -clone GL-1- for M1 phenotype
and CD206-APC -clone C08C02- for M2 phenotype) by
fluorescence-activated cell sorting (FACS).
Co-culture Model to Study the Crosstalk of
Cells Exposed to Different Oxygen
Environments
A custom-made co-culture system based on a thin membrane
permeable to oxygen was designed to investigate the interaction
between cells simultaneously subjected to differential
oxygen microenvironment. The device consists of two
polydimethylsiloxane (PDMS) well layers separated by a
37.5µm thick commercially available membrane (Gel-Pak,
Hayward, CA) (Figure 2). The membrane constitutes a gas
permeable substrate for cell culture. Oxygen concentration over
the cell culture can be tightly controlled via direct diffusion
through the gas permeable membrane from a gas source (Gas
Blender 100 Series, MCQ Instruments, Rome, Italy) connected
to the lower layer. More specifically, the time required for the gas
stimulus to diffuse through the Gel-Pak membrane was ∼5 s as
previously determined (12). The setting was designed to allow
commercially available transwell inserts to be nested in the wells
of the upper layer, thus enabling the performance of a cell co-
culture by seeding cells both on the upper surface of the porous
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FIGURE 1 | Simplified drawing showing the oxygenation gradient from the blood vessel to tumor cells. Circulating macrophages and endothelial cells lining the tumor
vessel are exposed to the physiological oxygen concentrations in blood (∼12 O2) while oxygen levels within the tumor decline as the distance from the functional
blood vessel increases.
membrane of the transwell and on the Gel-Pak membrane,
which are separated by a distance of 3mm. Therefore, cells
cultured on the transwell insert could be exposed to either the
same or different oxygen levels to those cells growing on the
chip surface, by modulating the oxygen concentration in the gas
mixture provided by the gas blender and oxygen levels in the cell
culture incubator.
The setting was constructed using polylactic acid (PLA) (RS
Components, Madrid, Spain) molds designed with Autodesk
123D Design software and printed with an Ultimaker-2 3D
printer (Ultimaker, Geldermalsen, The Netherlands). The code
driving the 3D printer is provided in Supplementary Materials.
The molds were employed to fabricate PDMS layers via replica
molding. Essentially, a PDMS mixture (Sylgard 184 kit, Dow
Corning, MI) prepared as described before (12) was poured onto
PLA molds, degassed in a vacuum desiccator (Kartell Labware,
Noviglio, Italy) and cured in an oven (Selecta, Barcelona, Spain)
at 65◦C for 3 h. Then, PDMS replicas were bonded to the Gel-
Pak membrane using plasma treatment as described previously
(12). Subsequently, the central region of the assembled device was
drilled to allow the passage of a tube to connect wells of the lower
layer to the gas source. Finally, the base of the device was adhered
into a 100mm diameter culture dish (Techno Plastic Products
AG) using PDMS and the lid was also drilled to enable the passage
of the inlet tube. This fabrication process is illustrated by a video
provided in the Supplementary Materials.
The actual values of oxygen partial pressure (PO2) at cell
level (on top of the transwell insert and on top of the PDMS
membrane) were measured in real time by using an O2 sensor
(FireStingO2, PyroScience, Aachen, Germany), a fiber-optic
oxygen meter (Figure 2).
Experimental Groups
B16F10, E0771, RENCA, and RAW264.7 single cultures
maintained in T-25 flasks were employed to perform the
experiments. Immediately before tumor cell seeding, the cell
culture devices were UV-sterilized, and membranes were
surface-coated with proteins of the extracellular matrix as
previously described (12). More specifically, 100µg/ml type
I collagen (Cultrex, Trevigen Inc., Gaithersburg, MD) or
10µg/ml fibronectin were employed for E0771 and B16F10
cell cultures, respectively. Then, 1.5ml of complete growth
medium containing 65,000 B16F10, 75,000 E0771, or 80,000
RENCA cells were added to each well. Tumor cells were allowed
to settle on the Gel-Pak membrane and maintained at 5%
CO2 balanced-air, 37◦C and 100% humidity in a standard
cell culture incubator for 24 h. Then, commercial transwell
inserts with 8µm pore polycarbonate membrane (Corning
Inc., NY) were nested in wells of the upper compartment.
Subsequently, 150,000 RAW264.7 cells suspended in 0.3ml
of serum-deprived medium were added on top of the porous
membrane. Then, the devices were placed in a cell culture
incubator at 37◦C and 100% humidity and connected to a gas
source providing a gas mixture with either 20% O2 (normoxia)
or 1% O2 (hypoxia) for 24 h. Tumor cells and macrophages
were cultured under same (20% O2) (N-N) or different oxygen
concentrations [1% O2 for tumor cells and 17% O2 (16–19%) for
macrophages] (H-N) simulating the standard conditions in cell
research or those conditions representative of the tumor-vessel
interface, respectively. Cells cultured in each experiment were
obtained from the trypsinization of different subcultures in
order to perform six independent cell co-cultures per device.
Experiments were performed in duplicate: one for the assessment
of macrophage migration and tumor cell proliferation and the
second to determine the M1/M2 polarity of macrophages (n =
6). Moreover, single cultures of tumor cells on the surface of the
device were performed in duplicate in order to analyze potential
changes in cancer cell proliferation and expression of genes
involved in macrophage recruitment in response to oxygenation
levels. Similarly, single cultures of macrophages on the upper
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FIGURE 2 | Novel experimental in vitro setting to reproduce different oxygenation patterns between the tumor-vessel interface. (A) The device was performed by
assembling an upper (a) and a lower (c) chamber with a PDMS membrane (b) between both chambers. The wells of the upper chamber where adjusted to fit to a
conventional transwell insert. (B) Scheme of the novel in vitro experimental setting developed to study the interactions between tumor cells and macrophages
simultaneously exposed to different oxygen levels mimicking the pathophysiological conditions in the solid tumor microenvironment. (C) The novel setting was able to
produce an oxygen gradient as measured by an oxygen optical sensor.
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side of the porous membrane were also employed as negative
controls for the determination of macrophage migration.
Assessment of Macrophage Migration
At the end point of experiments, transwell inserts were
transferred to bottom plates containing 0.5ml of 1X PBS
supplemented with 2% FBS. Macrophages remaining on the
upper side of the porous membrane were removed using
cotton tipped applicators, and cells present in the lower side
were fixed and stained with hematoxylin and eosin (Panreac
AppliChem, Barcelona, Spain). Plates were placed on the stage
of an inverted microscope (Zeiss Axiovert S100, Oberkochen,
Germany) and bright field images of the lower face of the
porous membrane were acquired using a uEye SE camera (IDS
Imaging Development Systems Gmbh, Obersuln, Germany) and
5X magnification lens by an investigator who was blinded to the
treatment group. The regions containing hematoxylin/esosin-
stained cells were identified by an automated thresholding plugin
in ImageJ software (13). For each image, cell migration was
calculated as the quotient between the area of the transwell
membrane covered by cells and the total area of the image and
expressed as percent (×100). Cell migration was normalized to
the control group (N-N).
Assessment of M1/M2 Polarization of
Macrophages
To determine whether oxygen concentrations could exert
a potential effect on tumor cells affecting macrophage
polarization, CD86 and CD206 surface markers representative
for M1 (anti-tumoral) and M2 (pro-tumoral) macrophage
phenotypes, respectively, were appraised using fluorescence
activated cell sorting (FACS) analyses. In order to collect
RAW264.7 cells remaining on both sides of the transwell
membrane, the inserts were firstly rinsed with 1x PBS and then
transferred into bottom plates containing 0.05% trypsin/0.02%
ethylenediaminetetraacetic acid (Sigma-Aldrich). The obtained
cells were stained with CD86-PerCP/Cy5.5 and CD206-
APC fluorescence-conjugated antibodies and analyzed on a
FACS Canto II cytometer using FACS Diva 5.5 software (BD
Biosciences, San Jose, CA). Data were analyzed with FlowJo
software (Tree Star, San Carlos, CA) to compute the median
fluorescence intensities (MFI) of CD206 and CD86 markers.
Tumor Cell Proliferation
Tumor cells adherent to the Gel-Pak membrane were trypsinized
and labeled with CD45-FITC antibody to discard any
macrophage (CD45+ cells) that potentially could detach
and adhere to the tumor cell culture. In single cultures, the
same protocol was followed although CD45 staining was not
performed. Total number of tumor cells in the sample was
represented by the number of unstained live cells identified by
FACS.
Determination of PTGS2, VEGFA, and
EMAPII Gene Expression in Tumor Cells
At the end point of experiments, RNA was isolated from
tumor cell single cultures using the RNeasy kit (Qiagen,
Hilden, Germany) following manufacturers’ instructions. Then,
0.5 µg of RNA were employed to synthetize cDNA by
reverse transcription polymerase chain reaction (PCR; TaqMan
Reverse Transcription Reagents). Changes in the expression
of prostaglandin-endoperoxide synthase 2 (PTGS2), vascular
endothelial growth factor (VEGFA), and endothelial-monocyte
activating polypeptide II (EMAPII) genes were analyzed by
quantitative PCR using the Taqman Fast Advanced Master Mix
in a StepOne Plus thermocycler. Relative PTGS2, VEGFA, and
EMAPII gene expression was normalized to the expression of
peptidylprolyl isomerase A (PPIA) gene applying the 2−11Ct
method (14) to compute the fold change in expression of
these genes compared to baseline. Unless otherwise specified,
all reagents were purchased from ThermoFisher Scientific
(Waltham, MA).
Statistical Analysis
Data are presented as means with standard error (SE) bars
(n = 6). Differences in means between N-N and H-N groups
were analyzed by two-tailed t-tests (when applicable) or by the
Mann-Whitney test. Tumor cell proliferation was compared by
two-way analysis of variance (ANOVA) with type of culture
(single culture vs. co-culture) and gas condition (N-N vs. H-
N) as variables. Student-Newman-Keuls post hoc method was
employed for multiple comparisons. All statistical analyses were
performed with SigmaPlot (Systat Software, San Jose, CA) and
p < 0.05 were considered as statistically significant.
RESULTS
Generation of a Differential Oxygen
Microenvironment in the Co-culture Device
The wells of the novel cell device allowed the introduction of
commercially available transwell inserts to recreate a co-culture
of different cells with each simultaneously exposed to different
oxygen level (Figure 2A). Specifically, the cells cultured on the
conventional transwell insert can be exposed to either the same or
different oxygen levels to those cells growing on the chip surface
by modulating the oxygen concentration in the gas mixture
provided by the gas blender and oxygen levels in the cell culture
incubator. We set oxygen gradient to mimic in vivo conditions
(Figure 2B). Three types of tumor cells where subjected to
continuous hypoxia (1%O2) andmacrophages wheremaintained
to 16–19% O2 in co-culture (Figure 2C), as determined by a
fiber-optic oxygen sensor. This setting allowed us to study the
activation and migration of oxygenated macrophages in response
to hypoxic tumor cells.
Melanoma and Breast Tumor Cells
Exposed to Hypoxia Enhance Macrophage
Migration
As shown in Figure 3, tumor cells are essential to promote
macrophage migration to the lower side of the porous
membrane. When macrophages were in co-culture with either
melanoma or breast cancer cells exposed to hypoxia (hypoxia-
normoxia; H-N) their migration increased by ∼15% (p =
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FIGURE 3 | Macrophage migration through a permeable membrane in co-culture with mouse melanoma (B16F10), breast (E0771), or renal (RENCA) cancer cells
exposed to different oxygen levels. (A) Representative bright field images showing stained macrophages which migrated to the lower side of the transwell membrane
after 24 h in co-culture with melanoma, breast, or renal cancer cells cultured under normoxic conditions (N-N) or under a physiological gradient of oxygen (H-N). In the
absence of tumor cells (right), macrophages did not migrate through the transwell membrane. Scale bar = 250µm. (B) The number of macrophages (RAW 264.7)
that migrated to the lower side of the membrane was significantly higher when B16F10 (left) or E0771 (center) were selectively exposed to hypoxia (H-N) in
comparison to normoxia (N-N), while no differences were found between treatments in the migration of macrophages co-cultured with RENCA cells (right). Data were
normalized to the control group (20% O2).
0.015) and ∼70% (p < 0.001), respectively, in comparison to
20% O2 (normoxia-normoxia; N-N). Although RENCA cells
also promoted the migration of RAW264.7 cells to the lower
side of the transwell membrane, no significant changes were
observed in response to the different experimental conditions
(N-N and H-N). In the absence of tumor cells, the differential
oxygen concentration did not have any effect on macrophage
migration when comparing N-N and H-N groups (Figure 3A,
right). Therefore, macrophage migration through the porous
membrane was induced through soluble mediators produced by
tumor cells, rather than by the differences in the oxygen levels
between the upper and bottom compartments of the migration
assay system.
Hypoxia-Treated Melanoma and Breast
Tumor Cells Reduce M1 Expression in
Macrophages
In addition to an increased migratory capacity, macrophages
in co-culture with melanoma or breast cancer cells exposed to
hypoxia (H-N) showed a marked reduction in the expression of
CD86 (M1 marker) (19% ± 5; p = 0.021 and 20% ± 7; p =
0.031, respectively) when compared to normoxic oxygenation in
both compartments (N-N). In contrast, no significant changes
were observed in the expression of CD86 in macrophages co-
cultured with hypoxia-treated renal cancer cells respect to those
exposed to normoxia. In general, no differences in the CD206
marker were observed between groups. The resulting M2/M1
MFI ratio obtained in H-N conditions was also increased when
macrophages were co-cultured with melanoma (p = 0.018)
and breast cancer cells (p = 0.002) as compared with N-N
(Figure 4).
Hypoxia-Induced Melanoma Cell
Proliferation Is Further Increased in
Co-culture With Macrophages
As shown in Figure 5, the application of hypoxia (1% O2)
to melanoma cells in single culture for 24 h increased their
proliferation by 34 ± 8%, (p = 0.019) in comparison to the
corresponding values observed at 20% O2. Similarly, hypoxic
conditions promoted a trend toward an increased breast tumor
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FIGURE 4 | Assessment of macrophage polarity. (A) Representative graphs obtained during FACS analyses which depict the median fluorescence intensities (MFI) for
M1 and M2 markers in macrophages co-cultured with melanoma (left), breast (center) and renal (right) cancer cells exposed to hypoxia (H-N) or normoxia (N-N).
Hypoxia-treated melanoma and breast tumor cells reduced the M1-like polarization of macrophages (A), as reflected by an increase in the M2/M1 ratio compared to
that observed when both cell types were exposed to normoxia (N-N) No significant changes in the phenotype of macrophages were observed when co-cultured with
renal cancer cells exposed to different oxygen levels (B). The M2/M1 ratio was calculated as the ratio of the median fluorescence intensity (MFI) of CD206/CD86
surface markers.
cell proliferation (26 ± 8%, p = 0.060) compared to normoxia.
Notwithstanding, renal cancer cell proliferation was not affected
by oxygenation levels.
When melanoma or breast cancer cells were selectively
subjected to hypoxia in co-culture with macrophages (H-N),
they exhibited increased proliferation (60 ± 13%, p < 0.001
and 72 ± 13%, p < 0.001, respectively) when compared to
the N-N conditions. The increased proliferation under H-
N conditions was more pronounced in co-culture for breast
cancer cells (p = 0.002) when compared to single culture
under hypoxia (H). A similar trend, although no significant,
p = 0.058), was observed in co-cultures of melanoma cells (H-
N) when compared with single cultures (H). No significant
differences in renal cancer cell proliferation were observed in
response to different levels of oxygenation regardless of the
presence or absence of macrophages. Therefore, these findings
suggest the existence of a positive feedback loop between
breast and melanoma tumor cell proliferation and increased
migration of macrophages presenting an increased M2/M1 ratio
when subjected to differential oxygenation levels as traditionally
encountered in solid tumors.
Alterations in PTGS2, VEGFA, and EMAPII
Genes in Tumor Cells Following Hypoxia
Treatment
PTGS2 gene expression experienced a 2.7-fold increase in
breast cancer cells cultured under hypoxic conditions for
24 h when compared to normoxic conditions (p = 0.002),
suggesting a role for this factor in the higher macrophage
recruitment observed in H-N co-culture (Figure 6A).
Nonetheless, the expression of this gene was undetectable
by real-time polymerase chain reaction in melanoma and
renal cancer cell cultures, suggesting that other genes
rather than this one would be involved in the highest
recruitment of macrophages promoted by hypoxia-treated
melanoma cells. In this sense, a 2.7-fold increase (p =
0.002) in the expression of VEGFA in B16F10 cells was
detected in response to hypoxia (Figure 6B). Regarding
the expression of EMAPII, it was lower in hypoxia-
treated breast and melanoma tumor cells and remained
similar between H-N and N-N conditions for renal tumor
cells (Figure 6C).
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FIGURE 5 | Proliferation of melanoma, breast, and renal cancer cells.
Melanoma (upper) and breast (middle) cancer cells increased their proliferative
rates when cultured under low levels of oxygen either in single culture (H) or in
co-culture with normoxic macrophages (H-N) when compared to N and (N-N)
treatment groups, respectively. The hypoxia-induced proliferation observed in
single culture (H) was further enhanced when tumor cells were co-cultured
with normoxic macrophages (H-N). Renal cancer cell proliferation remained
similar among the different treatment groups (right).
DISCUSSION
The novel cell culture setting we developed enables improved
understanding of the processes leading to activation and
recruitment of host immune cells during tumor development.
In spite that tumor hypoxia has been widely suggested as a
main hallmark of solid cancers, the oxygen gradients experienced
by the different types of cells playing a role in tumors have
not been recreated in most experimental research because it
was not easy to mimic with the conventional in vitro settings
available. The practical approach presented here provides an
easy way to reproduce in vivo oxygen gradients and hence to
study the crosstalk between tumor cells and macrophages in
the presence of differential oxygen levels. As a proof-of-concept
of the potential usefulness of the setting, our results provide
support to the notion that divergent oxygenation patterns across
a gradient as observed in solid tumors play an important
role in the interaction between tumor cells and host immune
cells. Interestingly, we observed that the effects of a hypoxic
gradient between oxygenated macrophages and hypoxic cancer
cells on macrophage activation, recruitment and cancer cell
proliferation were cell type dependent, and most importantly
were different to those found when using conventional Boyden
chamber migration assays (where both cell types exposed to the
same oxygen levels).
It is now well-recognized that tumor associated macrophages
are key drivers of cancer progression, facilitating tumor growth,
invasiveness and neoplastic transformation (7, 9, 10, 15,
16). Resident macrophages, which are distributed throughout
every organ of the body, or bone-marrow derived monocytes
are massively recruited from the circulation to the tumor
microenvironment in response to chemoattractant molecules
secreted by cells within the tumor microenvironment (7, 15, 17).
To study the crosstalk of tumor cells with macrophages, different
adaptations of the original Boyden chamber assays have been
employed and have provided critical insights on the potential
mechanisms involved in such crosstalk (18–21). By using this
approach, a vast number of studies have assessed the migration,
invasion, and metastatic potential of tumor cells in co-culture
with macrophages (18, 20, 21).
Despite tumor hypoxia is raising great interest due to the
increased evidence linking low levels of oxygen with a more
aggressive tumoral phenotype and higher tumor resistance to
different forms of therapy (2, 4, 22–24), the number of studies
including hypoxia as a modifiable variable in the assessment of
interactions between cancer cells and macrophages and their
recruitment to the tumor is very scarce. Some of the available
studies have applied either hypoxia or normoxia to the cell co-
culture employing differentmodifications of the Boyden chamber
in order to compare the motility and/or invasiveness of tumor
cells and/or macrophages in different oxygen environments
(25). In a similar fashion, other investigators have pre-exposed
tumor cells and/or macrophages to hypoxia, and subsequently,
the hypoxic cells or supernatants were employed to test their
effects on macrophages and/or tumor cell malignancy (10, 18,
20). However, both of such abovementioned approaches have
notable limitations. For example, to study the mechanisms
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FIGURE 6 | Expression of macrophage recruitment-related genes in melanoma, breast, and cancer cells in response to hypoxia. PTGS2 (A) and VEGFA (B, center)
gene expression was upregulated in hypoxia-treated breast and melanoma cancer cells, respectively, in comparison to normoxia. (C) EMAPII gene expression was
reduced by hypoxia in breast (upper) and melanoma (center) tumor cells, while remained invariable in renal cancer cells (lower).
involved in the recruitment of macrophages to the hypoxic
tumor mass, Triphati et al. introduced macrophages in the
upper well of a modified Boyden chamber, while 24 h pre-
exposed hypoxic/normoxic breast cancer cells or conditioned
media were positioned into the lower wells (10). These authors
observed a markedly increased migration of macrophages in
response to breast cancer cells pre-exposed to hypoxia and
conditioned media. Thus, the tumor cells were not actually
exposed to hypoxia during their co-culture with macrophages,
while no crosstalk between cells occurred when conditioned
media was used. However, when the Boyden chamber was
subjected to hypoxia (i.e., both macrophages and tumor cells
were then simultaneously exposed to hypoxia), the authors
observed that the migration was reduced compared to the
findings observed when breast cancer cells were pre-exposed
to hypoxia. Therefore, we interpret these studies as indirectly
suggesting that the different oxygenation levels that are present
in cancer cells and circulating macrophages could foster the
directional migration and recruitment of macrophages into the
tumor stroma. Alternatively, some investigators have designed
3D culture systems to create a hypoxic gradient from the
periphery to the core of the sphere in an attempt to recreate
a “solid tumor sphere” (26, 27). Despite the fact that this
innovative methodology is able to generate an oxygen gradient,
the oxygen gradient itself is not well-controlled, and is potentially
dependent on the metabolic rate of the cancer cells and the
size of the sphere, thereby creating inordinate variability from
one experiment to the next (27). Furthermore, these 3D cultures
do not allow for the concurrent culture of two cell populations
separated at different oxygenation levels, a desirable situation
when studying the potential mechanisms responsible for cancer
cell invasion induced by macrophages. In the present study, we
have implemented a new setting that is capable of concurrently
subjecting two cell types to different oxygen levels mimicking
the tumor microenvironment. This novel approach allowed
us to evaluate changes in macrophage migration induced by
tumor cells when the latter were selectively exposed to hypoxia
in co-culture. Furthermore, in contrast to previously reported
microfluidic devices capable of generating different oxygenation
environments (28–31), the macroscale experimental setting
presented herein is easily implementable in most laboratories,
given its easy fabrication, low-cost, and expanded versatility. In
the present work, melanoma and breast cancer cells promoted
macrophage migration in vitro as previously reported for other
types of cancer cells (10, 32). Indeed, macrophages cultured in the
upper surface of the porous membrane in the absence of tumor
cells being concurrently cultured in the bottom compartment did
not migrate in either one of the two experimental groups (N-N
and H-N), thereby confirming that migration of macrophages is
induced by soluble factors being released by cancer cells rather
than by the oxygen gradient per se.
Two major macrophage phenotypes have been described,
namely the classically activated (M1) and alternatively activated
(M2) macrophages. These macrophages can be identified based
on their distinctive expression of several surface markers and
cytokine release (33). Concretely, M1 macrophages mainly
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express a series of pro-inflammatory cytokines leading to
effective tumoricidal properties, while M2 macrophages, which
secrete anti-inflammatory cytokines along with other angiogenic
molecules and factors suppressing inflammation, facilitate tumor
cell immune evasion and survival (34, 35). Based on the
observation that tumor cells can re-educate macrophages toward
an alternative phenotype, cancer treatments that are predicated
on immunotherapy are being increasingly designed to boost
the immune defenses against cancer, by either maintaining or
promoting the M1 macrophage phenotype (34, 36). We should
also remark that M2 macrophages can directly promote cancer
cell proliferation, migration and metastatic potential (37, 38). In
fact, tumor cells induce a shift toward M2 phenotype in isolated
macrophages and that such shift will be further accelerated under
exposures to sustained or cyclical hypoxia (15, 39). Here, we have
found that hypoxia increased the proliferation of melanoma and
breast cancer cells and, in addition, the crosstalk between hypoxic
tumor cells and normoxic macrophages (H-N) promoted
macrophage recruitment and reduced their polarization toward
a M1 phenotype and consequently increased their M2/M1 ratio
in a similar fashion to our previous findings from tumor
associated macrophages isolated from tumors of mice exposed
to intermittent hypoxia (IH) (39) and explaining the higher
recruitment of macrophages in the tumor microenvironment
(15). Moreover, the increased recruitment of these macrophages
by hypoxic tumor cells promoted further increases in their
proliferation, demonstrating the presence of an intensified
feedback loop when an oxygen gradient is applied. These findings
are in keeping with previous in vitro and in vivo reports showing
that migrated macrophages in response to pre-exposed breast
and melanoma cancer cells to hypoxia presented a marked
polarization toward the M2 phenotype (10, 40). Furthermore,
the exposure of melanoma and breast cancer cells to hypoxia
resulted in their increased proliferation as previously reported
(39, 41). On the other hand, renal cancer cell proliferationwas not
altered by oxygenation levels and macrophage recruitment and
polarization remained similar between the different conditions.
These results are in keeping with previous in vivo observations
from RENCA subcutaneous tumors in Balb/c mice subjected
to intermittent hypoxia compared to room air control (42).
Application of IH was not able to promote a pro-tumoral
phenotype in tumor-associated macrophages and no changes
in tumor growth or metastasis were found. Also, VEGFA gene
expression by RENCA cells was also not affected by IH in vitro
(42). Therefore, the differential response to the hypoxic stimulus
assessed in this study suggests that the effect of this stimulus is
highly cell type dependent and needs to be analyzed for each
specific cancer.
The model employed also showed that melanoma and
breast cancer cells attracted macrophages through paracrine
signaling, since no contact was present between the tumor cells
and macrophages. It has been widely described that hypoxia
inducible factor-1 (HIF-1) and nuclear factor-kappa B (NF-κB)
are activated in response to hypoxia (43–45), thus modulating
the expression of genes such as VEGFA, cyclooxygenase 2
(COX-2) and those encoding for a wide array of cytokines
and chemokines including EMAPII, endothelin-2 (EDN2) or
the monocyte chemoattractant protein 1 (MCP1), which have
been distinctly recognized as playing important roles in the
recruitment, polarization and survival of macrophages in tumors
(46–50). Other studies have reported that the overexpression of
PTGS2 and the accumulation of its by-product prostaglandin
E2 (PGE2) within hypoxic regions of several types of tumors
are associated with the increased recruitment and M2-like
polarization of macrophages that lead to poor cancer outcomes
(51). In fact, the treatment of celecoxib, a specific inhibitor of
COX-2, was able to suppress the IH-induced tumor growth
and macrophage activation (52). Similarly, VEGF can be also
released in response to hypoxia by both tumor and tumor
stroma cells, acting not only as a regulator and promoter of
angiogenesis, but also as a chemoattractant for macrophages (47,
53). In this line, EMAPII protein levels also increased in several
cancer types including melanoma, fibrosarcoma, colorectal and
hepatocellular carcinomas in response to hypoxia both in vitro
and in vivo (48, 54, 55). In the present study, qPCR analyses
revealed a higher expression of PTGS2 or VEGFA genes in
hypoxia-treated breast and melanoma cells, respectively. These
results suggest that, although PGE2 and VEGF are likely involved
in the reported changes in macrophage phenotype and their
increased recruitment in the presence of an oxygen gradient,
their activation seems to be tumor cell-specific. Regarding
EMAPII, mRNA levels were significantly lower in hypoxia-
treated melanoma and breast cancer cells as compared with
normoxic conditions. Nonetheless, the activation of EMAPII by
hypoxia remains controversial: although the upregulation of this
factor in response to hypoxia has been usually described, there
is a study that reports its downregulation in hypoxia-treated
uveal melanoma cells (48) and, in addition, other studies have
reported that the regulation of this mediator by hypoxia is more
likely exerted at the translational or post-translational level (56).
Regarding renal cancer cells, the existence of the same hypoxic
gradient did not exert any effect on the expression of VEGFA and
EMAPII genes, and therefore, in the concomitant macrophage
migration and polarization. For all these reasons, drawing any
clear conclusion about the exact molecular mechanisms involved
in the recruitment and polarization of macrophages requires
comprehensive studies including gene and protein arrays for each
specific tumor type.
In summary, the novel experimental setting described and
tested here is capable to maintain cells in co-culture and to
simultaneously expose each cell type to different oxygenation.
This experimental setting can be easily built by any conventional
3D printer using non-expensive materials thereby it can be
implemented by any laboratory investigating cell tumors under
realistic oxygenation microenvironments. We carried out proof-
of-concept experiments to illustrate the feasibility of the new
setting and to proof that oxygen gradients result in results
different from the ones obtained using the conventional setting
which is unable to recreate realistic gas partial pressure gradients.
Specifically, we have shown that oxygen gradients play a role
in modulating macrophage recruitment to the tumor, via the
promotion of increased macrophage migration and accelerated
polarization toward the M2 phenotypes, which in turn leads to
increased cancer cell proliferation. Interestingly, the response
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induced by the hypoxic gradient is also cancer type dependent
indicating that some tumors could be more sensitive to hypoxia.
Our experiments were not addressed to investigate in detail the
mechanism involved and therefore future research mimicking
differences in cell oxygenation are required to improve our
understanding of the mechanisms involved in the cross-talk
between tumor cells and other host cells such as fibroblasts,
immune cells, stem cells and adipocytes can occur. From a
practical perspective, it is noteworthy that the novel experimental
setting described here can be easily adapted to other types of
commercially available assays to study the interaction, migration,
invasion, and/or endothelial intra/extravasation of different types
of tumor stromal cells while they are exposed in physiologically
relevant, yet different oxygen partial pressure conditions. Since
the new experimental setting is also capable of reproducing the
cyclic hypoxia that is encountered in the tumor during aberrant
blood flow (12), it offers unique research opportunities in the
exploration of pathophysiological mechanisms and therapeutic
targeting focused on tumor hypoxia.
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